Beranda › Penyakit Paru Interstisial › Oregon › Bend
Uji klinis Penyakit Paru Interstisial di Bend, OR
7 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Bend (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
- USA003, Bend
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Menerima pesertaFase 3
- Clinical Research Site, Bend
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Menerima pesertaFase 3
- Summit Health, Bend
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaStudi observasional
- Summit Health, Bend
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
- USA003, Bend
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Menerima pesertaFase 2
- Bend Memorial Clinic, Bend
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Menerima pesertaStudi observasional
- Summit Health, Bend
Uji klinis Penyakit Paru Interstisial di kota lain
- New York City, NY19 studi
- Philadelphia, PA17 studi
- Los Angeles, CA15 studi
- Kansas City, KS14 studi
- Charleston, SC13 studi
- Durham, NC13 studi
- Houston, TX13 studi
- Chicago, IL13 studi
- Aurora, CO11 studi
- Ann Arbor, MI11 studi
- Birmingham, AL10 studi
- Salt Lake City, UT10 studi
Studi lain di Bend
- Hipertensi Paru7 studi
- Kanker Kolorektal5 studi
- Kanker Prostat5 studi
- Kanker Payudara4 studi
- Kanker (semua jenis)3 studi
- Melanoma3 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.